Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1653

1.

Olanzapine with ondansetron and dexamethasone for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in lung cancer.

Wang W, Lou G, Zhang Y.

Medicine (Baltimore). 2018 Sep;97(37):e12331. doi: 10.1097/MD.0000000000012331.

2.

Schnuppern an einem mit Isopropylalkohol getränkten Tupfer hilft bei Übelkeit.

Steurer J.

Praxis (Bern 1994). 2018 Jul;107(14):788-789. doi: 10.1024/1661-8157/a002994. German. No abstract available.

PMID:
29969966
3.

Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.

Ammar HO, Mohamed MI, Tadros MI, Fouly AA.

AAPS PharmSciTech. 2018 Jul;19(5):2276-2287. doi: 10.1208/s12249-018-1019-y. Epub 2018 May 29.

PMID:
29845503
4.

The C and E subunits of the serotonin 5-HT3 receptor subtly modulate electrical properties of the receptor.

Yaakob NS, Nguyen DT, Exintaris B, Irving HR.

Biomed Pharmacother. 2018 Jan;97:1701-1709. doi: 10.1016/j.biopha.2017.12.010. Epub 2017 Dec 8.

PMID:
29793334
5.

Cutaneous refractile foreign body microemboli with intravascular injection of oral medication.

Bercovici N, Russomanno K, Santoro F, Scola C, Murphy M, Elaba Z.

J Cutan Pathol. 2018 May;45(5):365-368. doi: 10.1111/cup.13125. Epub 2018 Mar 14.

PMID:
29430677
6.

A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.

Foo WC, Khong YM, Gokhale R, Chan SY.

Int J Pharm. 2018 Mar 25;539(1-2):165-174. doi: 10.1016/j.ijpharm.2018.01.047. Epub 2018 Feb 27.

PMID:
29414124
7.

Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example.

Habib BA, Sayed S, Elsayed GM.

Eur J Pharm Sci. 2018 Mar 30;115:352-361. doi: 10.1016/j.ejps.2018.01.044. Epub 2018 Jan 31.

PMID:
29407555
8.

Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy.

Kosinski TM, Brown MC, Zavala PJ.

Int J Pharm Compd. 2018 Jan-Feb;22(1):41-46.

PMID:
29385385
9.

Effect of a single dose of i.v. ondansetron on QTc interval in emergency department patients.

Li K, Vo K, Lee BK, Addo N, Coralic Z.

Am J Health Syst Pharm. 2018 Mar 1;75(5):276-282. doi: 10.2146/ajhp161070. Epub 2018 Jan 9.

PMID:
29317399
10.

Torsades de Pointes after Ondansetron Infusion in 2 Patients.

Lee DY, Trinh T, Roy SK.

Tex Heart Inst J. 2017 Oct 1;44(5):366-369. doi: 10.14503/THIJ-16-6040. eCollection 2017 Oct.

11.

Perioperative Gabapentin Improves Patient-Centered Outcomes After Inguinal Hernia Repair.

Quail J, Spence D, Hannon M.

Mil Med. 2017 Nov;182(11):e2052-e2055. doi: 10.7205/MILMED-D-17-00107.

PMID:
29087880
12.

Ondansetron treatment reduces rotavirus symptoms-A randomized double-blinded placebo-controlled trial.

Hagbom M, Novak D, Ekström M, Khalid Y, Andersson M, Lindh M, Nordgren J, Svensson L.

PLoS One. 2017 Oct 27;12(10):e0186824. doi: 10.1371/journal.pone.0186824. eCollection 2017.

13.

Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.

Culver MA, Richards EC, Jarrell DH, Edwards CJ.

J Emerg Med. 2017 Nov;53(5):629-634. doi: 10.1016/j.jemermed.2017.06.040. Epub 2017 Oct 5.

PMID:
28987314
14.

Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.

Tan J, Wang S, Liang X, Li CC, Zhang J, Zhao Z, Kong XR, Deng X, Peng L, Yang C.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26815. Epub 2017 Sep 22.

PMID:
28941006
15.

Evaluation of periprocedural hypersensitivity reactions.

Iammatteo M, Keskin T, Jerschow E.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):349-355.e2. doi: 10.1016/j.anai.2017.07.013. Epub 2017 Aug 31.

PMID:
28866307
16.

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy.

Abdel-Malek R, Abbas N, Shohdy KS, Ismail M, Fawzy R, Salem DS, Safwat E.

J Egypt Natl Canc Inst. 2017 Sep;29(3):155-158. doi: 10.1016/j.jnci.2017.05.001. Epub 2017 Aug 24.

17.
18.

The Effect of Ondansetron on Acute Opioid Tolerance in Patients Receiving Intrathecal Opioids Prior to Cesarean Delivery.

Greer KC, Terkawi AS, Tsang S, Singla P, Durieux ME, Tiouririne M.

Reg Anesth Pain Med. 2017 Sep/Oct;42(5):669-673. doi: 10.1097/AAP.0000000000000642.

19.

Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the pediatric emergency department: a randomized controlled trial.

Epifanio M, Portela JL, Piva JP, Ferreira CHT, Sarria EE, Mattiello R.

J Pediatr (Rio J). 2018 Jan - Feb;94(1):62-68. doi: 10.1016/j.jped.2017.06.004. Epub 2017 Aug 1.

20.

Co-administration of Cyclosporin A and Ondansetron decreases transient local cerebral ischemic injury in the mouse.

Murozono M, Miyashita R, Takeda A, Ynagita K, Sato E, Ogiwara Y.

Neuro Endocrinol Lett. 2017 Jul;38(3):163-168.

PMID:
28759183

Supplemental Content

Loading ...
Support Center